123 related articles for article (PubMed ID: 1521517)
1. Diagnosis and endocrine testing in acromegaly.
Chang-DeMoranville BM; Jackson IM
Endocrinol Metab Clin North Am; 1992 Sep; 21(3):649-68. PubMed ID: 1521517
[TBL] [Abstract][Full Text] [Related]
2. Hormonal diagnosis of GH hypersecretory states.
Grottoli S; Gasco V; Ragazzoni F; Ghigo E
J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
[TBL] [Abstract][Full Text] [Related]
3. Are there alternative tests for diagnosis of acromegaly?
Popovic V
J Endocrinol Invest; 2005; 28(11 Suppl International):73-4. PubMed ID: 16625850
[TBL] [Abstract][Full Text] [Related]
4. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system.
Minuto F; Resmini E; Boschetti M; Arvigo M; Sormani MP; Giusti M; Ferone D; Barreca A
Clin Endocrinol (Oxf); 2004 Jul; 61(1):138-44. PubMed ID: 15212656
[TBL] [Abstract][Full Text] [Related]
5. Current diagnostic guidelines for biochemical diagnosis of acromegaly.
Ferone D; Resmini E; Bocca L; Giusti M; Barreca A; Minuto F
Minerva Endocrinol; 2004 Dec; 29(4):207-23. PubMed ID: 15765030
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
Wass JA
J Endocrinol; 1997 Oct; 155 Suppl 1():S17-9; discussion S21. PubMed ID: 9389991
[TBL] [Abstract][Full Text] [Related]
7. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
[TBL] [Abstract][Full Text] [Related]
8. [The place of insulin-like growth factor I in the diagnosis of acromegaly].
Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G
Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444
[TBL] [Abstract][Full Text] [Related]
9. Use of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in the diagnosis of acromegaly and growth hormone deficiency in adults.
Thissen JP; Ketelslegers JM; Maiter D
Growth Regul; 1996 Dec; 6(4):222-9. PubMed ID: 8971551
[TBL] [Abstract][Full Text] [Related]
10. Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
Wass JA
J Endocrinol Invest; 2003; 26(7 Suppl):48-53. PubMed ID: 14604066
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Wiesli P; Zwimpfer C; Zapf J; Schmid C
Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
[TBL] [Abstract][Full Text] [Related]
12. [What is the value of determining immunoreactive GHRH in acromegaly?].
Müller B; de Marco D; Bürgi U; Mullis PE
Schweiz Med Wochenschr; 1999 Aug; 129(33):1152-61. PubMed ID: 10483668
[TBL] [Abstract][Full Text] [Related]
13. Establishment of reference values for endocrine tests--part V: acromegaly.
Endert E; van Rooden M; Fliers E; Prummel MF; Wiersinga WM
Neth J Med; 2006; 64(7):230-5. PubMed ID: 16929084
[TBL] [Abstract][Full Text] [Related]
14. [Study of disorders of the GH-IGF-I axis by monitoring levels of IGF-I binding protein].
Justová V; Lacinová Z
Sb Lek; 1998; 99(2):141-51. PubMed ID: 10536494
[TBL] [Abstract][Full Text] [Related]
15. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
16. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.
Bastemir M; Akin F; Yaylali GF
Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378
[TBL] [Abstract][Full Text] [Related]
17. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone releasing factor-test in acromegaly: comparison with other dynamic tests.
Losa M; Schopohl J; Stalla GK; Müller OA; von Werder K
Clin Endocrinol (Oxf); 1985 Aug; 23(2):99-109. PubMed ID: 3931944
[TBL] [Abstract][Full Text] [Related]
19. Acromegaly.
Dineen R; Stewart PM; Sherlock M
QJM; 2017 Jul; 110(7):411-420. PubMed ID: 26873451
[TBL] [Abstract][Full Text] [Related]
20. [Laboratory diagnosis of growth hormone].
Macchia V; Mariano A
Minerva Endocrinol; 1993 Sep; 18(3 Suppl 1):36-42. PubMed ID: 7910655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]